Results 91 to 100 of about 15,413 (214)
Abstract A 10‐year‐old, male neutered, Scottish Terrier was referred for progressive right forelimb lameness attributed to a firm spherical mass in the location of a previous digit I amputation, performed 13‐months prior to presentation. Radiographs revealed a well‐defined expansile lytic bone and soft tissue mass obliterating metacarpal I with smooth ...
Lauren Ho, Jamie‐Leigh Thompson
wiley +1 more source
Corticosteroid‐augmented interfascial injections for cancer pain management in a dog
Abstract A 9‐year‐old Rottweiler with metastatic osteosarcoma developed severe episodic pain following forelimb amputation and progression of neoplastic disease. Despite extensive multimodal systemic analgesia, including NSAIDs, gabapentin, amantadine and later amitriptyline, the dog showed persistent vocalisation and touch‐evoked pain in the axillary ...
Zita Julianna Szabo +3 more
wiley +1 more source
Ultrasound‐guided trigeminal nerve block as an analgesic adjunct in feline maxillectomy
Summary A 6‐year‐old, female, neutered, domestic shorthair cat was presented to our hospital for surgical management of an osteosarcoma involving the left maxilla. Computed tomography revealed a mass affecting the caudal aspect of the left maxilla with evidence of local invasion.
Elena Parra Martínez +1 more
wiley +1 more source
Putative lotilaner/milbemycin‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis in a dog
Abstract Stevens‒Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe skin and mucocutaneous reaction, characterised by extensive epidermal necrosis and skin sloughing. Drugs are common triggers, with reactions to a number of classes reported.
Matt McHale +3 more
wiley +1 more source
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson +13 more
wiley +1 more source
Abstract Aims To investigate whether the treatment effect of extended‐release buprenorphine (BUP‐XR) on opioid‐free days in opioid use disorder (OUD) is mediated by reductions in opioid craving and improvements in personal functioning. Design and setting Exploratory causal mediation analysis using VanderWeele's four‐way decomposition framework in a 24 ...
John Marsden +11 more
wiley +1 more source
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian +31 more
wiley +1 more source
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas +10 more
wiley +1 more source
Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan +2 more
wiley +1 more source

